Atlas of breast cancer early detection

September 20,2024

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial - The Lancet

ATLAS Trial of Continuing Adjuvant Tamoxifen to 10 Years versus Stopping at 5 Years for Early Breast Cancer

Atlas of breast cancer early detection

Breast: Ductal carcinoma

The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities: Trends in Cancer

Atlas of Film-Screen Mammography: 9780806738116: Medicine & Health Science Books @

Atlas Medical Center

Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study - The Lancet Global Health

The Precision Prevention Initiative

Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic

Early detection, advanced treatment improve breast cancer prognosis

Cancer screening statistics - Statistics Explained

Epidemiology of breast cancer - Wikipedia

Atlas of breast cancer early detection